SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

GE and GlaxoSmithKline team up for oncology testing Working to standardize diagnostic testing

Boosting access to primary care Increasing amount of physicians is not the answer

Federal government weighs in on antibiotic resistance Issues national strategy and calls for alternative treatments

A protein can speed up recovery after radiation and chemo Shows promise in animal experiments

Patient engagement solutions market expected to soar Will hit $13.7 billion by 2019

Big data platform designed for new value-based model Helps physicians improve outcomes while reducing costs

Hospitals saving billions on charity care ACA may save expansion state hospitals up to $4.2 billion in 2014

FDA approves GE's new PET/CT Higher sensitivity and field-of-view

Consensys joins forces with Oncology Services International A strategic alliance among ISOs

Checking in with the first installed MEVION S250 Assessing nine months of single room proton therapy

Dr. Frederic Fahey,
past president of SNMMI

Dose awareness isn't just for CT

by Carol Ko , Staff Writer
Ever since a few high-profile stories put CT dose under the media microscope in 2009, dose scrutiny has spilled over into other modalities — namely molecular imaging. Both governmental agencies like the Food and Drug Administration and the public have consequently expressed more interest in the topic.

"In Boston Children's Hospital, I see parents asking more questions about radiation, its risks, and what it means for their child," Dr. Frederic Fahey, past president-elect of 2012 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), told DOTmed News. Indeed, concern around radiation dose is commonly cited as one of the barriers to growth in the molecular imaging market.

Story Continues Below Advertisement

Click to see a vision of improved quality of care in the OR

A mobile C-arm with low power can cause a unit to overheat, leaving your team waiting as valuable minutes tick by. Click to learn about the new Cios Alpha - delivering the most powerful generator available in a mobile C-arm



Recognizing that dose awareness in molecular imaging is in its relative infancy, Fahey and colleague Dr. Adam Alessio, associate professor at the Imaging Research Laboratory at the University of Washington and Fahey's co-chair for the SNMMI Dose Optimization Working Group, endeavored to organize initiatives during Fahey's presidency that would help move dose awareness forward in the field.

Ultimately, the organization's goal is to help provide practitioners with as much information on dose optimization as it can — a goal that's easier said than done, since there are some logical hurdles to overcome around collecting that information.

For good measure

For example, SNMMI recently worked with the Intersocietal Accreditation Commission (IAC) to help do something that had been only done on a smaller scale before: collect data to see how much levels of radiation dose varied from center to center for the same scan — more specifically, PET and bone scans.

The society gathered and analyzed data submitted to the IAC from sites seeking accreditation — a total of 225 sites that performed MDP bone scans and 95 sites that performed FDG PET scans.

Though on average the median levels of radiation dose fell squarely in line with the levels recommended by the society, there was significant individual variation. On the bone scan side, one patient received 19 millicuries of radiation for another patient's 36. And the radiation levels for PET scans ranged from 3 to 23 millicuries, though the suggested range is 10-20.

Fahey cautions that the data might be biased, since centers that seek accreditation might be more scrupulous in their dose administration than centers that don't, but the study is still the largest review of its sort.

Manual labor

On the manufacturing end, CT dose reduction efforts have been met with measurably significant success, as there's been a big market to satisfy increased demand for lower dose technologies. But whether this momentum will translate over to molecular imaging is questionable.

Continue reading Dose awareness isn't just for CT...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
(1)

Mohan Doss

Dose reduction efforts in nuclear medicine are misguided

September 05, 2013 05:02

For diagnostic nuclear medicine, there has not been even a single report that has shown increased cancer risk from radiotracer usage. So, what are the dose reduction efforts going to gain us in terms of reduced cancers? Reduction of excess cancers from zero to zero? How can anyone justify all the dose reduction efforts, with no health benefit to patients?

Though dose reduction has been recommended by many leading scientists, government agencies, and the various professional organizations as being prudent based on the linear no-threshold (LNT) model, there is increasing amount of evidence for the invalidity of the LNT model and for the beneficial effects of low dose radiation including prevention of cancer and neurodegenerative diseases. So, there is no benefit to patients in terms of reduced cancer risks from these dose reduction efforts. Aggressive dose reduction efforts can result in poorer image quality, and this has been described in reports of dose reduction efforts in a recent meeting.

Such dose reduction efforts also tend to validate the current popular superstitious belief about the carcinogenicity of low dose radiation, and discourages and prevents study of its beneficial effects.

In view of the above, I would suggest suspending the current dose monitoring/reduction efforts, and return our focus to improving the image quality and diagnosis.

Mohan Doss
mohan.doss@fccc.edu

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED